Vision changes with SPMS can involve slow visual processing and motion sensitivity, but it’s possible to manage them.

In a longitudinal cohort study, patients with multiple sclerosis underwent cognitive evaluation and magnetic resonance imaging scans at baseline and after 3 years. Memory decline was observed in ...

A 65-year-old woman with relapsing-remitting multiple sclerosis (RRMS) presents with blurred vision that is worse in the right eye. She denies diplopia and eye pain. Uncorrected visual acuity was ...

Biomedical scientists reports a drug -- an estrogen receptor ligand called indazole chloride (IndCl) -- has the potential to improve vision in patients with multiple sclerosis, or MS. The study was ...

One common symptom of multiple sclerosis (MS) is vision impairment, and it can progress to blindness in some cases. Now, researchers at the University of California, Riverside report a drug that was ...

Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. | Contineum Therapeutics’ M1 receptor ...

New research by Dorothy P. Schafer, PhD, at the University of Massachusetts Medical School, reveals the molecular process in which synaptic connections in the brain are damaged in multiple sclerosis ...